Share-based Payment Arrangement, Expense in USD of LEXICON PHARMACEUTICALS, INC. from Q3 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Lexicon Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q3 2011 to Q3 2025.
  • Lexicon Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $3.4M, a 21.4% increase year-over-year.
  • Lexicon Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $11.1M, a 27% decline year-over-year.
  • Lexicon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $13.5M, a 5.59% decline from 2023.
  • Lexicon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $14.3M, a 24.3% increase from 2022.
  • Lexicon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11.5M, a 8.49% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

LEXICON PHARMACEUTICALS, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $11.1M $3.4M +$600K +21.4% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 $10.5M $3.2M -$1.7M -34.7% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 $12.2M $3M -$1.3M -30.2% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $13.5M $1.5M -$1.7M -53.1% 01 Oct 2024 31 Dec 2024 10-K 07 Mar 2025
Q3 2024 $15.2M $2.8M -$1.1M -28.2% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 $16.3M $4.9M +$1.1M +28.9% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025
Q1 2024 $15.2M $4.3M +$900K +26.5% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 $14.3M $3.2M 01 Oct 2023 31 Dec 2023 10-K 07 Mar 2025
Q3 2023 $3.9M 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024
Q2 2023 $3.8M 01 Apr 2023 30 Jun 2023 10-Q 02 Aug 2024
Q1 2023 $3.4M 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024
Q3 2016 $1.9M +$200K +11.8% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2016
Q2 2016 $2M +$200K +11.1% 01 Apr 2016 30 Jun 2016 10-Q 04 Aug 2016
Q1 2016 $1.8M -$200K -10% 01 Jan 2016 31 Mar 2016 10-Q 05 May 2016
Q3 2015 $1.7M +$200K +13.3% 01 Jul 2015 30 Sep 2015 10-Q 07 Nov 2016
Q2 2015 $1.8M $0 0% 01 Apr 2015 30 Jun 2015 10-Q 04 Aug 2016
Q1 2015 $2M -$300K -13% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016
Q3 2014 $1.5M -$300K -16.7% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015
Q2 2014 $1.8M -$100K -5.26% 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015
Q1 2014 $2.3M +$200K +9.52% 01 Jan 2014 31 Mar 2014 10-Q 05 May 2015
Q3 2013 $1.8M +$200K +12.5% 01 Jul 2013 30 Sep 2013 10-Q 06 Nov 2014
Q2 2013 $1.9M +$300K +18.8% 01 Apr 2013 30 Jun 2013 10-Q 07 Aug 2014
Q1 2013 $2.1M +$400K +23.5% 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014
Q3 2012 $1.6M +$200K +14.3% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013
Q2 2012 $1.6M 01 Apr 2012 30 Jun 2012 10-Q 01 Aug 2013
Q1 2012 $1.7M 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013
Q3 2011 $1.4M 01 Jul 2011 30 Sep 2011 10-Q 07 Nov 2012

LEXICON PHARMACEUTICALS, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $13.5M -$800K -5.59% 01 Jan 2024 31 Dec 2024 10-K 07 Mar 2025
2023 $14.3M +$2.8M +24.3% 01 Jan 2023 31 Dec 2023 10-K 07 Mar 2025
2022 $11.5M +$900K +8.49% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2025
2021 $10.6M 01 Jan 2021 31 Dec 2021 10-K 25 Mar 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.